These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28119134)

  • 1. Erythropoietin as a performance-enhancing drug: Its mechanistic basis, detection, and potential adverse effects.
    Salamin O; Kuuranne T; Saugy M; Leuenberger N
    Mol Cell Endocrinol; 2018 Mar; 464():75-87. PubMed ID: 28119134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoiesis-stimulating agents: development, detection and dangers.
    Franz SE
    Drug Test Anal; 2009 Jun; 1(6):245-9. PubMed ID: 20355203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping.
    Pitsiladis YP; Durussel J; Rabin O
    Br J Sports Med; 2014 May; 48(10):856-61. PubMed ID: 24627340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin.
    Jelkmann W
    Front Horm Res; 2016; 47():115-27. PubMed ID: 27348128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current markers of the Athlete Blood Passport do not flag microdose EPO doping.
    Ashenden M; Gough CE; Garnham A; Gore CJ; Sharpe K
    Eur J Appl Physiol; 2011 Sep; 111(9):2307-14. PubMed ID: 21336951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection by LC-MS/MS of HIF stabilizer FG-4592 used as a new doping agent: Investigation on a positive case.
    Buisson C; Marchand A; Bailloux I; Lahaussois A; Martin L; Molina A
    J Pharm Biomed Anal; 2016 Mar; 121():181-187. PubMed ID: 26808067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin and erythropoiesis stimulating agents.
    Debeljak N; Sytkowski AJ
    Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
    Robinson N; Sottas PE; Schumacher YO
    Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring recombinant human erythropoietin abuse among athletes.
    Citartan M; Gopinath SCB; Chen Y; Lakshmipriya T; Tang TH
    Biosens Bioelectron; 2015 Jan; 63():86-98. PubMed ID: 25058943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and confirmatory analysis of recombinant human erythropoietin for racing camels' doping control.
    Delcourt V; Garcia P; Chabot B; Loup B; Remy P; Popot MA; Bailly-Chouriberry L
    Drug Test Anal; 2020 Jun; 12(6):763-770. PubMed ID: 31984676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.
    Diamanti-Kandarakis E; Konstantinopoulos PA; Papailiou J; Kandarakis SA; Andreopoulos A; Sykiotis GP
    Sports Med; 2005; 35(10):831-40. PubMed ID: 16180943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.
    Wang G; Durussel J; Shurlock J; Mooses M; Fuku N; Bruinvels G; Pedlar C; Burden R; Murray A; Yee B; Keenan A; McClure JD; Sottas PE; Pitsiladis YP
    BMC Genomics; 2017 Nov; 18(Suppl 8):817. PubMed ID: 29143667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary blood doping-Performance, mechanism, and detection.
    Breenfeldt Andersen A; Nordsborg NB; Bonne TC; Bejder J
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14243. PubMed ID: 36229224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of biological markers indicative of doping: the athlete biological passport.
    Saugy M; Lundby C; Robinson N
    Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current implementation and future of the Athlete Biological Passport.
    Sottas PE; Vernec A
    Bioanalysis; 2012 Jul; 4(13):1645-52. PubMed ID: 22831480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
    Leuenberger N; Saugy J; Mortensen RB; Schatz PJ; Giraud S; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):15-9. PubMed ID: 21816551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.